Medical Detox in Tennessee
Composite analysis
Treatment Access Pressure Index
Tennessee sits in the top quarter of states for treatment access pressure. Demand signals are elevated and verified provider supply is thin relative to population.
TAPI is a CCIWA composite. Each input is z-scored across 50 states plus DC and Puerto Rico, then combined as a weighted sum (HPSA 30%, frequent mental distress 25%, unemployment 15%, treatment density 30%, sign-flipped). The result is rescaled 0 to 100 by percentile rank. Read the full methodology.
Detox alone has a dismal track record for opioid use disorder. The reason is biological, not motivational. Once tolerance drops, relapse risk during the first two weeks after discharge is the highest of any window in the disease. Tennessee runs its Medicaid program with methadone, buprenorphine, and naltrexone covered, which means the state has the medication infrastructure to bridge from detox into real treatment if a program chooses to use it.
What changes by state
| Factor | Tennessee |
|---|---|
| Medicaid covers methadone | Yes |
| Medicaid covers buprenorphine | Yes |
| Medicaid covers residential SUD | Yes |
| 1115 SUD waiver | Limited (TennCare block grant/HAO waiver proposal is the relevant authority; SUD-specific IMD waiver status unclear) |
| IMD exclusion status | TennCare operates through managed care with 'in lieu of' authority potentially applicable for IMD services; standalone SUD IMD 1115 waiver not confirmed |
| Drug overdose deaths (2023) | 3,616 |
What to ask any Tennessee detox program
The five questions on our detox overview page apply everywhere, but two of them tighten up here based on what Tennessee Medicaid actually pays for. If buprenorphine is not started before discharge, that is a major clinical red flag. If a program tells you methadone is "not allowed" during detox, that is incorrect under federal rule and worth a second opinion.
If you have already detoxed
The single highest-leverage move after detox is a same-week MOUD appointment. Tennessee OTPs can induct same day or next day in most cases. Buprenorphine prescribers in Tennessee can often do an in-office induction within 48 hours.
For the full coverage breakdown including prior authorization rules and continuity of care obligations, see the Tennessee insurance guides are coming soon.